Human Genome Epidemiology Literature Finder
Records 1 - 15 (of 15 Records) |
Query Trace: SLC47A2[original query] |
---|
Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients. Pharmacogenetics and genomics 2010 Feb 20 (2): 135-8. Toyama Kana, Yonezawa Atsushi, Tsuda Masahiro, Masuda Satohiro, Yano Ikuko, Terada Tomohiro, Osawa Riyo, Katsura Toshiya, Hosokawa Masaya, Fujimoto Shimpei, Inagaki Nobuya, Inui Ken-Ic |
A common 5'-UTR variant in MATE2-K is associated with poor response to metformin. Clinical pharmacology and therapeutics 2011 Nov 90 (5): 674-84. Choi J H, Yee S W, Ramirez A H, Morrissey K M, Jang G H, Joski P J, Mefford J A, Hesselson S E, Schlessinger A, Jenkins G, Castro R A, Johns S J, Stryke D, Sali A, Ferrin T E, Witte J S, Kwok P-Y, Roden D M, Wilke R A, McCarty C A, Davis R L, Giacomini K |
Functional characterization of MATE2-K genetic variants and their effects on metformin pharmacokinetics. Pharmacogenetics and genomics 2013 Jul 23 (7): 365-73. Chung Jae-Yong, Cho Sung Kweon, Kim Tae Hee, Kim Kyoung Hee, Jang Geun Hye, Kim Choon Ok, Park Eun-Mi, Cho Joo-Youn, Jang In-Jin, Choi Ji |
Genetic polymorphisms of multidrug and toxin extrusion proteins (MATE1 and MATE2) in South Indian population. BioImpacts : BI 2017 7 (1): 25-30. Raj Gerard Marshall, Mathaiyan Jayanthi, Wyawahare Mukta, Rao Katiboina Srinivasa, Priyadarshini Rek |
Implication of critical pharmacokinetic gene variants on therapeutic response to metformin in Type 2 diabetes. Pharmacogenomics 2018 Jun . Phani Nagaraja M, Vohra Manik, Kakar Ananth, Adhikari Prabha, Nagri Shivashankara K, D'Souza Sydney C, Umakanth Shashikiran, Satyamoorthy Kapaettu, Rai Padmalatha |
Lack of effect of the SLC47A1 and SLC47A2 gene polymorphisms on the glycemic response to metformin in type 2 diabetes mellitus patients. Drug metabolism and personalized therapy 2018 Dec 33 (4): 175-185. Raj Gerard Marshall, Mathaiyan Jayanthi, Wyawahare Mukta, Priyadarshini Rek |
Influence of pharmacogenetic polymorphisms and demographic variables on metformin pharmacokinetics in an admixed Brazilian cohort. British journal of clinical pharmacology 2018 Jan . Santoro Ana Beatriz, Botton Mariana Rodrigues, Struchiner Claudio José, Suarez-Kurtz Guilher |
Effects of SLC22A2 (rs201919874) and SLC47A2 (rs138244461) genetic variants on Metformin Pharmacokinetics in Pakistani T2DM patients. JPMA. The Journal of the Pakistan Medical Association 2019 Feb 69 (2): 155-163. Moeez Sadaf, Khalid Zoya, Jalil Fazal, Irfan Muhammad, Ismail Muhammad, Arif Mohammad Ali, Niazi Rauf, Khalid Sumb |
Evaluation of the suitability of 19 pharmacogenomics biomarkers for individualized metformin therapy for type 2 diabetes patients. Drug metabolism and personalized therapy 2020 Jun . Xhakaza Lettilia, Abrahams-October Zainonesa, Pearce Brendon, Masilela Charity Mandisa, Adeniyi Oladele Vincent, Johnson Rabia, Ongole Joven Jebio, Benjeddou Mon |
Evaluation of the suitability of 19 pharmacogenomics biomarkers for individualized metformin therapy for type 2 diabetes patients. Drug metabolism and personalized therapy 2020 Jun 35 (2): . Xhakaza Lettilia, Abrahams-October Zainonesa, Pearce Brendon, Masilela Charity Mandisa, Adeniyi Oladele Vincent, Johnson Rabia, Ongole Joven Jebio, Benjeddou Mon |
Population diversity of three variants of the SLC47A2 gene (MATE2-K transporter) in Mexican Mestizos and Native Americans. Molecular biology reports 2021 8 48 (9): 6343-6348. Favela-Mendoza Alma Faviola, Fricke-Galindo Ingrid, Cuevas-Sánchez Wendy Fernanda, Aguilar-Velázquez José Alonso, Martínez-Cortés Gabriela, Rangel-Villalobos Héct |
Characterization of cytochrome P450 (CYP) 2D6 drugs as substrates of human organic cation transporters and multidrug and toxin extrusion proteins. British journal of pharmacology 2021 1 178 (6): 1459-1474. Neul Claudia, Hofmann Ute, Schaeffeler Elke, Winter Stefan, Klein Kathrin, Giacomini Kathleen M, Eichelbaum Michel, Schwab Matthias, Nies Anne |
Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus. Pharmacogenomics 2023 8 . Noelia Pérez-Gómez, María Dolores Fernández-Ortega, Miren Elizari-Roncal, Estefanía Santos-Mazo, Laura de la Maza-Pereg, Sara Calvo, Raquel Alcaraz, Antonio Sanz-Solas, Raquel Vinuesa, Miriam Saiz-Rodrígu |
Identification of Transporter Polymorphisms Influencing Metformin Pharmacokinetics in Healthy Volunteers. Journal of personalized medicine 2023 3 13 (3): . Saiz-Rodríguez Miriam, Ochoa Dolores, Zubiaur Pablo, Navares-Gómez Marcos, Román Manuel, Camargo-Mamani Paola, Luquero-Bueno Sergio, Villapalos-García Gonzalo, Alcaraz Raquel, Mejía-Abril Gina, Santos-Mazo Estefanía, Abad-Santos Francis |
Impact of solute carrier transporter gene polymorphisms on serum creatinine concentrations in healthy volunteers. Pharmacology research & perspectives 2023 1 11 (1): e01048. Yokoyama Satoshi, Nakagawa Junichi, Kudo Masakiyo, Aiuchi Naoya, Seito Tatsuya, Isida Mizuri, Mikami Tatsuya, Ihara Kazushige, Nakaji Shigeyuki, Niioka Takeno |
- Page last reviewed:Feb 1, 2024
- Page last updated:Jun 17, 2024
- Content source: